|
| |
BioPortfolio's Approved Drugs DatabaseVelcadeBortezomibDownload PDF containing detailed information.
Press Releases About Velcade:
|
 |
| Approved Lymphoma Drug Shows Promise in Early Tests Against Bone Cancer |
5th November, 2009 |
University of Rochester Medical Center |
ROCHESTER, N.Y., Nov. 5 /PRNewswire-USNewswire/ -- A drug already approved for the treatment of lymphoma may also slow the growth of the most deadly bone cancer in children and teens, according to an
|
| AEterna Zentaris Partner, Keryx, Presented Updated Phase 2 Data on Perifosine (KRX-0401) for the Treatment of Advanced Metastatic Renal Cell Carcinoma at 8th International Kidney Cancer Symposium in Chicago |
29th September, 2009 |
AETERNA ZENTARIS INC. |
Perifosine Continues to Demonstrate Impressive Efficacy, Safety and
Tolerability in Metastatic Renal Cell Carcinoma Patients who Progressed
after Failing Treatment with both a VEGF
|
| Reportlinker Adds World Market for Cancer Therapeutics and Biotherapeutics, 3rd. Edition, The Report |
24th September, 2009 |
Reportlinker |
-- SERMS
The report includes market share by type of cancer and market share by company for each of the three major segments. It also includes statistical information for cancers by type
|
| Keryx Biopharmaceuticals, Inc. to Hold Investor/Analyst Day Tomorrow |
21st September, 2009 |
Keryx Biopharmaceuticals, Inc. |
-- Dr. Anderson's team at Dana-Farber Cancer Institute led clinical
trials in multiple myeloma of the novel proteasome inhibitor Velcade(R),
as well as the immunomodulatory
|
| New Report Just Published: World Multiple Myeloma Therapeutics Market Report |
7th July, 2009 |
Reportlinker |
NEW YORK, July 7 /PRNewswire/ -- Reportlinker.com just added a new market research report to its catalogue.
World Multiple Myeloma Therapeutics Market
http://www.reportlinker.com/p0119496/World
|
Companies working in the area of Velcade from Bioportfolio's Biocorporate database : | |
| Company Name | |
Millennium Pharmaceuticals, Inc., a leading biopharmaceutical company based in Cambridge, Mass., markets VELCADEŽ (bortezomib) for Injection, a novel cancer therapeutic, and has a robust clinical...
www.mlnm.com/ View full profile
| |
Nereus Pharmaceuticals is an innovative drug discovery and development company pursuing untapped sources of chemical diversity and identifying drug candidates derived from marine microbes. In the past...
www.nereuspharm.com/ View full profile
| |
This page has been viewed 35 times
Recent Search Terms used to find this page: .
Browse BioPortfolio's InDepth service - alphabetically:
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
or by Most Publications, recently searched for, or
most viewed.
Search for Velcade across BioPortfolio, or for Velcade Research Reports
Wikipedia excerpt, where present, licenced under the GNU Free Documentation License. Resources from the NCBI applied. Selected MeSH subject headings created and maintained by the US NLM are used in conjunction with additional keywords. 2006-2008 MeSH.
Thumbshots from Thumbshots.org
|
